Christopher Radcliffe, MD
Clinical FellowAbout
Research
Publications
2026
The Clean Margin in Diabetic Foot Osteomyelitis: Conceptual Appeal, Practical Uncertainty.
Radcliffe CV, Golden M, Datta R. The Clean Margin in Diabetic Foot Osteomyelitis: Conceptual Appeal, Practical Uncertainty. Clin Infect Dis 2026 PMID: 42536505, DOI: 10.1093/cid/ciag467.Peer-Reviewed Original ResearchWords and Worms: The Nosology of Strongyloidiasis
Radcliffe C, Vinetz J. Words and Worms: The Nosology of Strongyloidiasis. American Journal Of Tropical Medicine And Hygiene 2026, 115: 19-21. PMID: 42086043, PMCID: PMC13326908, DOI: 10.4269/ajtmh.26-0113.Peer-Reviewed Original ResearchDisseminated mucormycosis
Radcliffe C, Tremblay E, Machiavello Roman F. Disseminated mucormycosis. IDCases 2026, 43: e02514. PMID: 41717056, PMCID: PMC12914299, DOI: 10.1016/j.idcr.2026.e02514.Peer-Reviewed Original ResearchBellini and Balloon Pumps: Art in the Cardiac Intensive Care Unit
RADCLIFFE C, DUDZINSKI D. Bellini and Balloon Pumps: Art in the Cardiac Intensive Care Unit. Journal Of Cardiac Failure - Intersections 2026, 2: 89-91. DOI: 10.1016/j.yjcafi.2025.10.015.Peer-Reviewed Original Research
2025
Bellini and Balloon Pumps: Art in the Cardiac Intensive Care Unit
Radcliffe CV , Dudzinski DM. Bellini and Balloon Pumps: Art in the Cardiac Intensive Care Unit, Journal of Cardiac Failure - Intersections (2025), doi: https://doi.org/10.1016/j.yjcafi.2025.10.015Peer-Reviewed Original ResearchLactobacillus Bacteremia and Endovascular Infections: A Retrospective Study of 100 Patients
Radcliffe C, Anahtar M, Hohmann E, Turbett S, Dugdale C, Paras M. Lactobacillus Bacteremia and Endovascular Infections: A Retrospective Study of 100 Patients. Open Forum Infectious Diseases 2025, 12: ofaf466. PMID: 40852136, PMCID: PMC12368416, DOI: 10.1093/ofid/ofaf466.Peer-Reviewed Original ResearchBlood culturesRetrospective cohort studyDefinite endocarditisBlood culture contaminationEndovascular infectionPrimary outcomeRetrospective cohort study of patientsCohort study of patientsModified Duke criteriaInitial blood culturePrimary analysisAntimicrobial susceptibility dataBlood culture setsProportion of patientsStudy of patientsBroth microdilution methodInjection drug useAll-Cause MortalityDuke criteriaGastrointestinal commensalsLactobacillus bacteremiaBloodstream infectionsPolymicrobial infectionsRetrospective studyIntracardiac devicesVaccination strategies for solid organ transplant candidates and recipients: insights and recommendations
Radcliffe C, Kotton C. Vaccination strategies for solid organ transplant candidates and recipients: insights and recommendations. Expert Review Of Vaccines 2025, 24: 313-323. PMID: 40184037, DOI: 10.1080/14760584.2025.2489659.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsSolid organ transplant candidatesVaccine-preventable infectionsOrgan transplant candidatesTransplant candidatesImmunocompromised patientsClinical effectsRespiratory syncytial virus vaccineClinical effectiveness of vaccinationSolid organ transplant recipientsOrgan transplant recipientsPre-transplant vaccinationPost-transplant periodPost-transplant vaccinationTransplant recipientsImmunocompromised adultsProspective studyVaccine responseVaccine trialsVaccination strategiesVaccine efficacyVirus vaccineGuideline statementsEffect of vaccinationIndividual vaccinesViral vaccines
2024
Travel Medicine for Immunocompromised Travelers: An Essential Layer of Protection
Radcliffe C, Kotton C. Travel Medicine for Immunocompromised Travelers: An Essential Layer of Protection. Current Treatment Options In Infectious Diseases 2024, 17: 2. DOI: 10.1007/s40506-024-00277-y.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsAntimicrobial prophylaxisImmunocompromised travelersExposure to respiratory virusesRespiratory syncytial virusPre-travel counsellingTravel medicineImmunocompetent counterpartsImmunocompromised patientsTravel-related vaccinesSeasonal influenzaRespiratory virusesSyncytial virusInfectious riskProphylaxisVaccineInfection riskMass transitTravelRiskPractice of travel medicineIndividualized approachVirusAgency guidelinesContingency plansInfluenzaTravel Medicine for Immunocompromised Travelers: An Essential Layer of Protection
Radcliffe C, Kotton CN. Travel medicine for immunocompromised travelers: An essential layer of protection. Curr Treat Options Infect Dis. 2025;17(2). doi: 10.1007/s40506-024-00277-yPeer-Reviewed Original ResearchEn Garde or On Board? Travel Medicine for Immunocompromised Patients in the COVID-19 Era.
Radcliffe C, Kotton C. En Garde or On Board? Travel Medicine for Immunocompromised Patients in the COVID-19 Era. Annals Of Internal Medicine 2024, 177: 667-669. PMID: 38588541, DOI: 10.7326/m24-0256.Commentaries, Editorials and Letters